GeneDx Holdings Corp. (WGS)
40.75
+1.90
(+4.89%)
USD |
NASDAQ |
May 15, 16:00
41.00
+0.25
(+0.61%)
After-Hours: 20:00
GeneDx Holdings EPS Diluted (Quarterly) : -2.158 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Quest Diagnostics, Inc. | 2.241 |
| Labcorp Holdings, Inc. | 3.351 |
| Psychemedics Corp. | -- |
| Fulgent Genetics, Inc. | -0.8039 |
| Guardant Health, Inc. | -0.8538 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -63.32M |
| Revenue (Quarterly) | 102.25M |
| Total Expenses (Quarterly) | 165.57M |
| Enterprise Value | 1.207B |
| Gross Profit Margin (Quarterly) | 61.48% |
| Profit Margin (Quarterly) | -61.92% |
| Earnings Yield | -6.55% |
| Normalized Earnings Yield | -4.336 |